Beneficiaries
Helmholz Munich (coordinator), Germany
Bayer Aktiengesellschaft, Germany
Pfizer Pharma GmbH, Germany (since 01/12/2022)
Janssen Pharmaceutica NV , Belgium
Enamine Limited Liability Company, Ukraine
Freie Universität Berlin, Germany
Katholieke Universiteit Leuven, Belgium
Johannes Kepler Universität Linz, Austria
Scuola Universitaria Professionale della Svizzera Italiana, Switzerland
TU Dortmund, Germany (01/2021 - 19/05/2022)
Johannes Gutenberg-Universität Mainz (since 01/03/2022)
Universiteit Leiden, Netherlands
Université du Luxembourg, Luxembourg
Universitat Pompeu Fabra, Spain
Vancouver Prostate Center, University of British Columbia, Canada (own contribution)
Associated Partners
Technical University of Munich, Germany
University of Southern Switzerland
Novartis Institutes for Biomedical Research, Switzerland
University of North Carolina at Chapel Hill, USA
La Trobe University, Australia
Instituto di Ricerche Farmacologiche "Mario Negri", Italy
Max Planck Institute of Molecular Physiology, Germany
Beijing University of Chemical Technology, China